| paclitaxel / Generic mfg. |
NCT00003237: Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach |
|
|
| Completed | 2 | 55 | US, RoW | cisplatin, paclitaxel, surgical procedure | Eastern Cooperative Oncology Group, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer | 10/03 | | | |
NCT00005599: Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer |
|
|
| Completed | 2 | | US | bryostatin 1, paclitaxel | Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer | | 08/04 | | |
NCT00154778: Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer |
|
|
| Completed | 2 | 55 | RoW | Taxol, UFT,Leucovorin | National Taiwan University Hospital, Taipei Veterans General Hospital, Taiwan, Tri-Service General Hospital, Mackay Memorial Hospital, National Cheng-Kung University Hospital, National Health Research Institutes, Taiwan | Gastric Cancer | | 06/05 | | |
NCT00022139: Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction |
|
|
| Completed | 2 | 56 | US | carboplatin, fluorouracil, paclitaxel, conventional surgery, radiation therapy | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer | 07/05 | 01/09 | | |
NCT00006081: Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer |
|
|
| Completed | 2 | 37 | US | Bryostatin-1, Paclitaxel (Taxol), Taxol | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer | 09/05 | 09/05 | | |
NCT00011960: Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery |
|
|
| Completed | 2 | | US | cisplatin, paclitaxel, adjuvant therapy, radiation therapy | Radiation Therapy Oncology Group, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer | 05/06 | | | |
NCT00009880: Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach |
|
|
| Completed | 2 | | US | filgrastim, cisplatin, fluorouracil, paclitaxel, radiation therapy | Radiation Therapy Oncology Group, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer | 07/06 | | | |
NCT01904435: Cetuximab, Paclitaxel, Carboplatin And Radiation For Esophageal, Gastroesophageal Junction And Gastric Cancer |
|
|
| Completed | 2 | 60 | US | Chemotherapy/Radiation, Cetuximab, paclitaxel, carboplatin and radiation then surgery | Brown University, Bristol-Myers Squibb | Esophageal Cancer, Gastric Cancer | 02/08 | 09/08 | | |
NCT01379482: Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer |
|
|
| Completed | 2 | 18 | Europe | Multimodal treatment, Irinotecan+Nordic FLv (6 pat.), EOX (6 pat.), FLOX (3 pat.), Docetaxel+Irinotecan+5-FU+LV (1 pat.), FOLFIRI (1 pat.), ECF (1 pat.), Cisplatin+doxorubicin (5 pat.)., Oxaliplatin +concomitant i.v. 5-FU+ i.v. LV (3 pat.), 5-FU + i.v. LV (5 pat.), Paclitaxel (1 pat.) | Uppsala University | Peritoneal Carcinomatosis, Gastric Cancer | 03/09 | 03/09 | | |
NCT00033657: Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer |
|
|
| Completed | 2 | 97 | US | cisplatin, cis-platinum, platinum, Platinol, Platinol-AQ, DDP, CDDP, DACP, NSC 119875, irinotecan hydrochloride, Camptothecin-11, CPT-11, Camptosar, paclitaxel, Taxol, NSC 125973, conventional surgery, radiation therapy | Eastern Cooperative Oncology Group, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer | 09/09 | 10/09 | | |
NCT00003298: Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer |
|
|
| Completed | 2 | 39 | US | cisplatin, Platinol, cis-platinum, cisdiamminedichloroplatinum (II), Platinol-AQ, DACP, platinum, CDDP, DDP, fluorouracil, 5-Fluorouracil, 5-FU, Adrucil, Efudex, leucovorin calcium, Leucovorin, Wellcovorin, citrovorum factor, folinic acid, 5-formyl tetrahydrofolate, LV, LCV, paclitaxel, Taxol®, NSC 125973, surgery, radiation therapy | ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI) | Gastric Cancer | 02/10 | 05/11 | | |
| Terminated | 2 | 960 | Japan, Canada, Europe, RoW | AZD4547, paclitaxel | AstraZeneca | Gastro-oesophageal Junction Cancer, Gastric Cancer | 08/13 | 02/15 | | |
|
NCT01830270: Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer |
|
|
| Terminated | 2 | 30 | Europe | Epirubicin, Cisplatin, Paclitaxel, gastric surgery | Centre Hospitalier Universitaire de Besancon | Stomach Neoplasms, Oesophageal Junction Cancer, Lower Oesophagus Cancer | 04/15 | 07/16 | | |
NCT01774851 / 2012-003798-25: A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach |
|
|
| Terminated | 2 | 84 | US | MM-111, Paclitaxel, Trastuzumab | Merrimack Pharmaceuticals | HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer, Stomach Cancer | 07/15 | 12/15 | | |
|
|
|
NCT02274012: Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment |
|
|
| Withdrawn | 2 | 0 | NA | Afatinib, BIBW 2992, Paclitaxel, Taxol | Columbia University, Boehringer Ingelheim | HER-2 Positive Gastric Cancer, Gastrooesophageal Cancer, Esophageal Cancer | 08/15 | 08/15 | | |
NCT01283204: Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer |
|
|
| Completed | 2 | 180 | RoW | SP, TS-1® with Cisplatin, FL/Tax, Paclitaxel with Leucovorin with 5-FU, FL/Doc, Docetaxel with Leucovorin with 5-FU, FOLFOX, Oxaliplatin with Leucovorin with 5-FU | Yonsei University | Recurrent or Metastatic Gastric Cancer | 07/16 | 07/16 | | |
NCT00209612: Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC. |
|
|
| Withdrawn | 1/2 | 40 | Japan | Taxol, Paclitaxel, Campt, Topotesin, irinotecan | Hokkaido Gastrointestinal Cancer Study Group, Hokkaido University Hospital | Gastric Cancer | 11/08 | 03/09 | | |
| Completed | 1/2 | 42 | RoW | Paclitaxel and irinotecan | Seoul National University Hospital | Advanced Gastric Cancer | 06/11 | 08/11 | | |
NCT01746771: A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer |
|
|
| Completed | 1/2 | 44 | RoW | HM781-36B(Poziotinib), NOV120101, Poziotinib, Paclitaxel, Trastuzumab, Herceptin | Hanmi Pharmaceutical Company Limited, National OncoVenture | HER-2 Positive Advanced Gastric Cancer | 08/15 | 08/15 | | |
| Completed | 1/2 | 35 | RoW | RAD001, RAD001 with Paclitaxel 175 mg/m2 and carboplatin (AUC=5) on Day 1, every 3 weeks until PD | Chinese University of Hong Kong | Gastric Cancer | 03/19 | 03/19 | | |
